Blood And Blood Products Market 2026

November 2025 | 220 pages | ID: BA4E6DACD50FEN
DataM Intelligence

Abstracts

The Blood And Blood Products Market was valued at in and is anticipated to reach by , at a CAGR of 0.07 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Blood And Blood Products Market.

This report delivers a comprehensive overview of the Blood And Blood Products Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood And Blood Products Market. The Blood And Blood Products Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

Blood And Blood Products Market Scope:

By Product

• Whole Blood
• Blood Components

By Application

• Anemia
• Trauma and Surgery
• Cancer Treatment
• Bleeding Disorders

By Blood Components

• Red blood cells
• White blood cells
• Platelets

By End User

• Hospitals
• Blood and Blood component bank
• Diagnostic Laboratories
• Ambulatory Surgical Centers
• Others

By Competitive Landscape

• Key Developments and Strategies
• Company Share Analysis
• Product Benchmarking
• Key Companies to Watch

By Company Profiles

• Medtronic Plc
• American Red Cross
• Sarstedt AG & Co.
• Australian Red Cross Blood Service
• Abbott Laboratories
• Blood Centers of America
• Becton,Dickinson & Co
• German Red Cross
• Nipro Medical Corporation
• American Association of Blood Banks
• National Blood Authority Australia
• Vitalant
• Baxter International Inc
• Immucor
• Novartis
• Novo Nordisk
• Ortho Clinical Diagnostics
• Roche Diagnostics
• Fresenius Kabi(LIST NOT EXHAUSTIVE)

Major Highlights

This report delivers a comprehensive overview of the Blood And Blood Products Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood And Blood Products Market. The Blood And Blood Products Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet by Product
3.2. Market snippet by Application
3.3. Market snippet by Blood Components
3.4. Market snippet by End User
3.5. Market Snippet by Region

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Surge in demand for blood and plasma across the globe.
    4.1.1.2. Rise in geriatric population worldwide
    4.1.1.3. Restraints:
      4.1.1.3.1. High cost of advanced blood collection devices.
      4.1.1.3.2. Lack of skilled laboratory professionals hinder the growth of the market
      4.1.1.3.3. Opportunity

5. IMPACT ANALYSIS INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of Covid-19 on the Market
  6.1.1. Before COVID-19 Market Scenario
  6.1.2. Present COVID-19 Market Scenario
  6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY PRODUCT

7.1. Introduction
  7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  7.1.2. Market Attractiveness Index, By Product Segment
7.2. Whole Blood*
  7.2.1. Introduction
  7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.3. Blood Components

8. BY APPLICATION

8.1. Introduction
  8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  8.1.2. Market Attractiveness Index, By Application
8.2. Anemia*
  8.2.1. Introduction
  8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Trauma and Surgery
8.4. Cancer Treatment
8.5. Bleeding Disorders

9. BY BLOOD COMPONENTS

9.1. Red blood cells
  9.1.1. Introduction
  9.1.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.2. White blood cells
9.3. Platelets

10. BY END USER

10.1. Introduction
  10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  10.1.2. Market Attractiveness Index, By End User Segment
10.2. Hospitals*
  10.2.1. Introduction
  10.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
10.3. Blood and Blood component bank
10.4. Diagnostic Laboratories
10.5. Ambulatory Surgical Centers
10.6. Others

11. BY REGION

11.1. Introduction
  11.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Blood Components
  11.2.6. Market Size Analysis ,and Y-o-Y Growth Analysis (%), By End User
  11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.2.7.1. U.S.
    11.2.7.2. Canada
    11.2.7.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Blood Components
  11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%),By End User
  11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.3.7.1. Germany
    11.3.7.2. U.K.
    11.3.7.3. France
    11.3.7.4. Italy
    11.3.7.5. Spain
    11.3.7.6. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Blood Components
  11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.4.7.1. Brazil
    11.4.7.2. Argentina
    11.4.7.3. Rest of South America
11.5. Asia Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Blood Components
  11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.5.7.1. China
    11.5.7.2. India
    11.5.7.3. Japan
    11.5.7.4. Australia
    11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Blood Components
  11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. BY COMPETITIVE LANDSCAPE

12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
12.4. Key Companies to Watch

13. BY COMPANY PROFILES

13.1. Medtronic Plc*
  13.1.1. Company Overview
  13.1.2. Product Portfolio and Description
  13.1.3. Key Highlights
  13.1.4. Financial Overview
13.2. American Red Cross
13.3. Sarstedt AG & Co.
13.4. Australian Red Cross Blood Service
13.5. Abbott Laboratories
13.6. Blood Centers of America
13.7. Becton,Dickinson & Co
13.8. German Red Cross
13.9. Nipro Medical Corporation
13.10. American Association of Blood Banks
13.11. National Blood Authority Australia
13.12. Vitalant
13.13. Baxter International Inc
13.14. Immucor
13.15. Novartis
13.16. Novo Nordisk
13.17. Ortho Clinical Diagnostics
13.18. Roche Diagnostics
13.19. Fresenius Kabi(*LIST NOT EXHAUSTIVE)

14. DATAM INTELLIGENCE

14.1. Appendix
14.2. About Us and Services
14.3. Contact Us